no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Adverse events associated with dietary supplements
|
|
|
2003 |
934 |
1 |
p. 5 |
article |
2 |
Amiodarone-induced thyroid disorders associated with total dose
|
|
|
2003 |
934 |
1 |
p. 5 |
article |
3 |
Anticoagulants: increased risk of complications in cancer patients
|
|
|
2003 |
934 |
1 |
p. 4 |
article |
4 |
Antiretrovirals
|
|
|
2003 |
934 |
1 |
p. 6 |
article |
5 |
Argatroban/lepirudin/warfarin
|
|
|
2003 |
934 |
1 |
p. 6 |
article |
6 |
Arsenic trioxide
|
|
|
2003 |
934 |
1 |
p. 6-7 |
article |
7 |
BCG vaccine
|
|
|
2003 |
934 |
1 |
p. 7 |
article |
8 |
Benzocaine
|
|
|
2003 |
934 |
1 |
p. 7 |
article |
9 |
Celecoxib: recurrent ulcer bleeding similar to diclofenac + omeprazole
|
|
|
2003 |
934 |
1 |
p. 5 |
article |
10 |
Cerivastatin interaction
|
|
|
2003 |
934 |
1 |
p. 7 |
article |
11 |
Clozapine
|
|
|
2003 |
934 |
1 |
p. 7 |
article |
12 |
Estrogens
|
|
|
2003 |
934 |
1 |
p. 7 |
article |
13 |
Fludarabine
|
|
|
2003 |
934 |
1 |
p. 7-8 |
article |
14 |
Gefitinib
|
|
|
2003 |
934 |
1 |
p. 8 |
article |
15 |
HAART: a cause of hypothyroidism?
|
|
|
2003 |
934 |
1 |
p. 5 |
article |
16 |
Herbal medicines
|
|
|
2003 |
934 |
1 |
p. 8 |
article |
17 |
High level of nevirapine discontinuation due to AEs
|
|
|
2003 |
934 |
1 |
p. 4 |
article |
18 |
Hydroxycarbamide
|
|
|
2003 |
934 |
1 |
p. 8 |
article |
19 |
Ibutilide
|
|
|
2003 |
934 |
1 |
p. 8 |
article |
20 |
Interferon-β-1a
|
|
|
2003 |
934 |
1 |
p. 9 |
article |
21 |
Interferon-α-2b
|
|
|
2003 |
934 |
1 |
p. 9 |
article |
22 |
Interferon-α withdrawal
|
|
|
2003 |
934 |
1 |
p. 9 |
article |
23 |
Isosorbide dinitrate
|
|
|
2003 |
934 |
1 |
p. 9-10 |
article |
24 |
Linezolid
|
|
|
2003 |
934 |
1 |
p. 10 |
article |
25 |
Metformin: contraindication guidelines need amending
|
|
|
2003 |
934 |
1 |
p. 3 |
article |
26 |
Nicorandil
|
|
|
2003 |
934 |
1 |
p. 10 |
article |
27 |
Nimesulide
|
|
|
2003 |
934 |
1 |
p. 10 |
article |
28 |
Nitrous oxide
|
|
|
2003 |
934 |
1 |
p. 10-11 |
article |
29 |
Nitrous oxide
|
|
|
2003 |
934 |
1 |
p. 10 |
article |
30 |
Ranitidine
|
|
|
2003 |
934 |
1 |
p. 11 |
article |
31 |
Risk-benefit assessment of nimesulide urgently needed
|
|
|
2003 |
934 |
1 |
p. 3 |
article |
32 |
Risk of serious infection with `Kineret' + etanercept
|
|
|
2003 |
934 |
1 |
p. 2 |
article |
33 |
Risperidone
|
|
|
2003 |
934 |
1 |
p. 11 |
article |
34 |
Safety of newer antidepressants and antihistamines in Canada
|
|
|
2003 |
934 |
1 |
p. 2 |
article |
35 |
Sildenafil improves SRI-associated sexual dysfunction
|
|
|
2003 |
934 |
1 |
p. 4 |
article |
36 |
Stavudine/zidovudine
|
|
|
2003 |
934 |
1 |
p. 11 |
article |
37 |
UK bans kavain due to liver toxicity
|
|
|
2003 |
934 |
1 |
p. 3 |
article |
38 |
UK MCA to reinstate licenses for anorectics
|
|
|
2003 |
934 |
1 |
p. 3 |
article |
39 |
Warfarin interaction
|
|
|
2003 |
934 |
1 |
p. 11-12 |
article |
40 |
Wyeth adds boxed warning to HT products
|
|
|
2003 |
934 |
1 |
p. 2 |
article |